Report Detail
Global Age Related Macular Degeneration Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM2839355 |
- 13 August, 2024 |
- Global |
- 90 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Age Related Macular Degeneration Treatment market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 9565.8 million by 2030 with a CAGR of 2.7% during review period.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
The age-related macular degeneration (AMD) treatment market is driven by the increasing prevalence of AMD, particularly in the aging population. As the global elderly population grows, the demand for effective treatment options to manage and slow down AMD progression rises. Additionally, advancements in medical research and technology have led to the development of novel therapies, such as anti-VEGF drugs, which have significantly improved visual outcomes for AMD patients. However, challenges exist, including the high cost of treatment, especially for long-term therapies, and the need for early detection and diagnosis to ensure timely intervention. Overcoming these challenges through affordable treatment options, patient education, and continued research to identify new therapeutic targets will be crucial for the sustained growth of the age-related macular degeneration treatment market.
The Global Info Research report includes an overview of the development of the Age Related Macular Degeneration Treatment industry chain, the market status of Hospital (Lucentis, Eylea), Clinic (Lucentis, Eylea), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Age Related Macular Degeneration Treatment.
Regionally, the report analyzes the Age Related Macular Degeneration Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Age Related Macular Degeneration Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Age Related Macular Degeneration Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Age Related Macular Degeneration Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Lucentis, Eylea).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Age Related Macular Degeneration Treatment market.
Regional Analysis: The report involves examining the Age Related Macular Degeneration Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Age Related Macular Degeneration Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Age Related Macular Degeneration Treatment:
Company Analysis: Report covers individual Age Related Macular Degeneration Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Age Related Macular Degeneration Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Age Related Macular Degeneration Treatment. It assesses the current state, advancements, and potential future developments in Age Related Macular Degeneration Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Age Related Macular Degeneration Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Age Related Macular Degeneration Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Lucentis
Eylea
Avastin
Other
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Age Related Macular Degeneration Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Age Related Macular Degeneration Treatment, with revenue, gross margin and global market share of Age Related Macular Degeneration Treatment from 2019 to 2024.
Chapter 3, the Age Related Macular Degeneration Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Age Related Macular Degeneration Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Age Related Macular Degeneration Treatment.
Chapter 13, to describe Age Related Macular Degeneration Treatment research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Age Related Macular Degeneration Treatment
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Age Related Macular Degeneration Treatment by Type
- 1.3.1 Overview: Global Age Related Macular Degeneration Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Age Related Macular Degeneration Treatment Consumption Value Market Share by Type in 2023
- 1.3.3 Lucentis
- 1.3.4 Eylea
- 1.3.5 Avastin
- 1.3.6 Other
- 1.4 Global Age Related Macular Degeneration Treatment Market by Application
- 1.4.1 Overview: Global Age Related Macular Degeneration Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Age Related Macular Degeneration Treatment Market Size & Forecast
- 1.6 Global Age Related Macular Degeneration Treatment Market Size and Forecast by Region
- 1.6.1 Global Age Related Macular Degeneration Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Age Related Macular Degeneration Treatment Market Size by Region, (2019-2030)
- 1.6.3 North America Age Related Macular Degeneration Treatment Market Size and Prospect (2019-2030)
- 1.6.4 Europe Age Related Macular Degeneration Treatment Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Age Related Macular Degeneration Treatment Market Size and Prospect (2019-2030)
- 1.6.6 South America Age Related Macular Degeneration Treatment Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Age Related Macular Degeneration Treatment Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Regeneron Pharmaceuticals
- 2.1.1 Regeneron Pharmaceuticals Details
- 2.1.2 Regeneron Pharmaceuticals Major Business
- 2.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product and Solutions
- 2.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
- 2.2 Bayer HealthCare
- 2.2.1 Bayer HealthCare Details
- 2.2.2 Bayer HealthCare Major Business
- 2.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Product and Solutions
- 2.2.4 Bayer HealthCare Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Bayer HealthCare Recent Developments and Future Plans
- 2.3 Novartis
- 2.3.1 Novartis Details
- 2.3.2 Novartis Major Business
- 2.3.3 Novartis Age Related Macular Degeneration Treatment Product and Solutions
- 2.3.4 Novartis Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Novartis Recent Developments and Future Plans
- 2.4 Roche
- 2.4.1 Roche Details
- 2.4.2 Roche Major Business
- 2.4.3 Roche Age Related Macular Degeneration Treatment Product and Solutions
- 2.4.4 Roche Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Roche Recent Developments and Future Plans
- 2.5 Kanghong Pharma
- 2.5.1 Kanghong Pharma Details
- 2.5.2 Kanghong Pharma Major Business
- 2.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Product and Solutions
- 2.5.4 Kanghong Pharma Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Kanghong Pharma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Age Related Macular Degeneration Treatment Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Age Related Macular Degeneration Treatment by Company Revenue
- 3.2.2 Top 3 Age Related Macular Degeneration Treatment Players Market Share in 2023
- 3.2.3 Top 6 Age Related Macular Degeneration Treatment Players Market Share in 2023
- 3.3 Age Related Macular Degeneration Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Age Related Macular Degeneration Treatment Market: Region Footprint
- 3.3.2 Age Related Macular Degeneration Treatment Market: Company Product Type Footprint
- 3.3.3 Age Related Macular Degeneration Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Age Related Macular Degeneration Treatment Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Age Related Macular Degeneration Treatment Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Age Related Macular Degeneration Treatment Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Age Related Macular Degeneration Treatment Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Age Related Macular Degeneration Treatment Consumption Value by Type (2019-2030)
- 6.2 North America Age Related Macular Degeneration Treatment Consumption Value by Application (2019-2030)
- 6.3 North America Age Related Macular Degeneration Treatment Market Size by Country
- 6.3.1 North America Age Related Macular Degeneration Treatment Consumption Value by Country (2019-2030)
- 6.3.2 United States Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 6.3.3 Canada Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Age Related Macular Degeneration Treatment Consumption Value by Type (2019-2030)
- 7.2 Europe Age Related Macular Degeneration Treatment Consumption Value by Application (2019-2030)
- 7.3 Europe Age Related Macular Degeneration Treatment Market Size by Country
- 7.3.1 Europe Age Related Macular Degeneration Treatment Consumption Value by Country (2019-2030)
- 7.3.2 Germany Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 7.3.3 France Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 7.3.5 Russia Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 7.3.6 Italy Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Age Related Macular Degeneration Treatment Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Age Related Macular Degeneration Treatment Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region
- 8.3.1 Asia-Pacific Age Related Macular Degeneration Treatment Consumption Value by Region (2019-2030)
- 8.3.2 China Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 8.3.3 Japan Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 8.3.5 India Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 8.3.7 Australia Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Age Related Macular Degeneration Treatment Consumption Value by Type (2019-2030)
- 9.2 South America Age Related Macular Degeneration Treatment Consumption Value by Application (2019-2030)
- 9.3 South America Age Related Macular Degeneration Treatment Market Size by Country
- 9.3.1 South America Age Related Macular Degeneration Treatment Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Age Related Macular Degeneration Treatment Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Age Related Macular Degeneration Treatment Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country
- 10.3.1 Middle East & Africa Age Related Macular Degeneration Treatment Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
- 10.3.4 UAE Age Related Macular Degeneration Treatment Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Age Related Macular Degeneration Treatment Market Drivers
- 11.2 Age Related Macular Degeneration Treatment Market Restraints
- 11.3 Age Related Macular Degeneration Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Age Related Macular Degeneration Treatment Industry Chain
- 12.2 Age Related Macular Degeneration Treatment Upstream Analysis
- 12.3 Age Related Macular Degeneration Treatment Midstream Analysis
- 12.4 Age Related Macular Degeneration Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Age Related Macular Degeneration Treatment . Industry analysis & Market Report on Age Related Macular Degeneration Treatment is a syndicated market report, published as Global Age Related Macular Degeneration Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Age Related Macular Degeneration Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
